Clinical Trial Update: Radiolabel ADME (Absorption, Distribution, Metabolism, and Excretion) Study Of [14C] PF-00868554 In Healthy Adult Male Subjects [Phase 1]

View source ↗

Summary

Pfizer completed a Phase 1 radiolabel ADME study of PF-00868554 in healthy adult male subjects for hepatitis C.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• PF-00868554

Snippet

Sponsor: Pfizer | Conditions: HCV | Phase 1 | Status: COMPLETED